Drug Profile
Repifermin
Alternative Names: FGF-10; HG 03400; Keratinocyte growth factor-2; KGF-2Latest Information Update: 04 Feb 2004
Price :
$50
*
At a glance
- Originator GlaxoSmithKline; Human Genome Sciences
- Class Fibroblast growth factors
- Mechanism of Action Fibroblast growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mucositis; Neutropenia; Ulcerative colitis; Varicose ulcer
Most Recent Events
- 04 Feb 2004 Discontinued - Phase-II for Neutropenia in USA (unspecified route)
- 04 Feb 2004 Discontinued - Phase-II for Ulcerative colitis in USA (unspecified route)
- 04 Feb 2004 Discontinued - Phase-II for Mucositis in USA (IV)